EBMT 45th (2019)

Drupal spam blocked by CleanTalk.
Title Content type
Posaconazole vs fluconazole eficacy and safety of antifungal prophylaxis on patients with allogenic stem cell transplantation. Experience of a mexican center (click for details)
Pharmacokinetic-pharmacodynamic analyses of dose selection for rezafungin prophylaxis against invasive fungal infections in blood and marrow transplantation (click for details)
Antifungal prophylaxis with posaconazole versus fluconazole in children with neutropenia following hematopoietic stem cell transplanation (click for details)
Is fungal prophylaxis necessary in non myeloablative peripheral blood stem cell allogeneic transplantation in the pre-engrafment period? (click for details)
Pulmonary invasive fungal disease after community acquire respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients: Results from a prospective observational study (click for details)
Invasive pulmonary aspergillosis after allogeneic hematopoietic stem cell transplantation. Study over a period of 3 years (click for details)
Antifungal prophylaxis with fluconazole or fluconazole followed by posaconazole in high risk patients in allogeneic setting (click for details)
Isavuconazole use in paediatric hematopoietic stem cell transplantation: The experience of infectious disease working group of Italian association of pediatric hematology oncology (AIEOP) (click for details)
Budesonide - a not so topical glucocorticosteroid? - The relevance of drug interactions (click for details)
Invasive fungal diseases before and after allogeneic hematopoietic stem cell transplantation in patients with hodgkin's lymphoma (click for details)


Subscribe to EBMT 45th (2019)